Breaking News, Trials & Filings

Trials & Filings in Brief: Jan. 6, 2014

Alkermes, DiaVacs, Kala, Oxygen Biotherpeutics, Peregrine, TauRx

Phase III
Oxygen posts LCOS trial protocol . . . read more

TauRx adds research centers for Alzheimer’s studies . . . read more

Filings
Alkermes receives MMF patent . . . read more

DiaVacs gets orphan status for T1DM immunotherapy . . . read more

Kala files IND for post-cataract treatment . . . read more

Peregrine gets Fast Track for NSCLC biologic . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters